InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
T+90 胜率
67%
T+90 平均收益
-0.8%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Hecht Peter M, 首席执行官. Officer active across 1 company, notably Cyclerion Therapeutics, Inc.. In total, 8 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €3.4m. History available since 4 May 2021. The latest transaction was filed on 25 March 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hecht Peter M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
351,037 股Common StockSEC:0001193125-26-309048:0
181,818 股@ US$2.755.4% 占其流量Common StockSEC:0000950170-25-046280:0
15,000 股0Common StockSEC:0000950170-24-007920:0
20,000 股0Common StockSEC:0000950170-23-067738:0
225,000 股@ US$8.6821.3% 占其流量Common StockSEC:0001140361-23-026101:0
823,170 股@ US$3.2839.2% 占其流量Common StockSEC:0001140361-21-020090:0
标准退出：2021年9月1日 (T+90)
302,000 股@ US$2.4310.7% 占其流量Common StockSEC:0001140361-21-016532:0
标准退出：2021年8月4日 (T+90)
300,000 股@ US$2.2910.1% 占其流量Common StockSEC:0001140361-21-016304:0
标准退出：2021年8月2日 (T+90)
8 条申报中的 8 条
About Hecht Peter M
Hecht Peter M is the Chief Executive Officer of Cyclerion Therapeutics, Inc. In this role, he is responsible for the strategic direction of the company and the management of its operations. His leadership is essential in guiding the organization toward its goals, ensuring it remains competitive and innovative in the biotechnology sector.
